These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 28225470)

  • 1. Life-threatening Tachyarrhythmia Following Intra-Arterial Milrinone for Cerebral Vasospasm.
    Vimala S; Madhusudhan S; Sahoo BK
    J Neurosurg Anesthesiol; 2018 Jul; 30(3):281-283. PubMed ID: 28225470
    [No Abstract]   [Full Text] [Related]  

  • 2. Which Protocol for Milrinone to Treat Cerebral Vasospasm Associated With Subarachnoid Hemorrhage?
    Crespy T; Heintzelmann M; Chiron C; Vinclair M; Tahon F; Francony G; Payen JF
    J Neurosurg Anesthesiol; 2019 Jul; 31(3):323-329. PubMed ID: 30015694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous intra-arterial dilatation with nimodipine and milrinone for refractory cerebral vasospasm.
    Anand S; Goel G; Gupta V
    J Neurosurg Anesthesiol; 2014 Jan; 26(1):92-3. PubMed ID: 23774116
    [No Abstract]   [Full Text] [Related]  

  • 4. Angiographic evaluation of the effect of intra-arterial milrinone therapy in patients with vasospasm from aneurysmal subarachnoid hemorrhage.
    Shankar JJ; dos Santos MP; Deus-Silva L; Lum C
    Neuroradiology; 2011 Feb; 53(2):123-8. PubMed ID: 20549498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous intravenous milrinone for severe reversible cerebral vasoconstriction syndrome (a case report).
    Lakhal K; Rodie-Talbere PA; Alexandre PL; Testard N; Rozec B; Daumas-Duport B
    J Neurol Sci; 2019 Feb; 397():55-57. PubMed ID: 30590342
    [No Abstract]   [Full Text] [Related]  

  • 6. Hemodynamic management and outcome of patients treated for cerebral vasospasm with intraarterial nicardipine and/or milrinone.
    Schmidt U; Bittner E; Pivi S; Marota JJ
    Anesth Analg; 2010 Mar; 110(3):895-902. PubMed ID: 20185665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Milrinone-Associated Cardiomyopathy and Arrhythmia in Cerebral Vasospasm.
    Wu EM; El Ahmadieh TY; Kafka B; Davies MT; Aoun SG; White JA
    World Neurosurg; 2018 Jun; 114():252-256. PubMed ID: 29609088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher dose intra-arterial milrinone and intra-arterial combined milrinone-nimodipine infusion as a rescue therapy for refractory cerebral vasospasm.
    Duman E; Karakoç F; Pinar HU; Dogan R; Fırat A; Yıldırım E
    Interv Neuroradiol; 2017 Dec; 23(6):636-643. PubMed ID: 28956512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seeking new approaches: milrinone in the treatment of cerebral vasospasm.
    Baumann A; Derelle AL; Mertes PM; Audibert G
    Neurocrit Care; 2012 Jun; 16(3):351-3. PubMed ID: 22576147
    [No Abstract]   [Full Text] [Related]  

  • 10. Milrinone for the treatment of cerebral vasospasm after subarachnoid hemorrhage: report of seven cases.
    Arakawa Y; Kikuta K; Hojo M; Goto Y; Ishii A; Yamagata S
    Neurosurgery; 2001 Apr; 48(4):723-8; discussion 728-30. PubMed ID: 11322432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Milrinone reduces cerebral vasospasm after subarachnoid hemorrhage of WFNS grade IV or V.
    Arakawa Y; Kikuta K; Hojo M; Goto Y; Yamagata S; Nozaki K; Hashimoto N
    Neurol Med Chir (Tokyo); 2004 Aug; 44(8):393-400; discussion 401. PubMed ID: 15508346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Milrinone for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
    Fraticelli AT; Cholley BP; Losser MR; Saint Maurice JP; Payen D
    Stroke; 2008 Mar; 39(3):893-8. PubMed ID: 18239182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic tolerance of intravenous milrinone administration for cerebral vasospasm secondary to non-traumatic subarachnoid hemorrhage.
    Julian N; Gaugain S; Labeyrie MA; Barthélémy R; Froelich S; Houdart E; Mebazaa A; Chousterman BG
    J Crit Care; 2024 Aug; 82():154807. PubMed ID: 38579430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Milrinone and homeostasis to treat cerebral vasospasm associated with subarachnoid hemorrhage: the Montreal Neurological Hospital protocol.
    Lannes M; Teitelbaum J; del Pilar Cortés M; Cardoso M; Angle M
    Neurocrit Care; 2012 Jun; 16(3):354-62. PubMed ID: 22528278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Milrinone as a rescue therapy for symptomatic refractory cerebral vasospasm in aneurysmal subarachnoid hemorrhage.
    Romero CM; Morales D; Reccius A; Mena F; Prieto J; Bustos P; Larrondo J; Castro J
    Neurocrit Care; 2009; 11(2):165-71. PubMed ID: 18202923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of intrathecal milrinone injection via lumbar catheter on delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.
    Koyanagi M; Fukuda H; Lo B; Uezato M; Kurosaki Y; Sadamasa N; Handa A; Chin M; Yamagata S
    J Neurosurg; 2018 Mar; 128(3):717-722. PubMed ID: 28298035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. May levosimendan be safe and effective in refractory vasospasm despite adequate treatment with repeated angiography and milrinone infusion after subarachnoid haemorrhage?
    Cottenceau V; Poutier B; Gariel F; Sauvage N; Petit L; Carrie C; Biais M
    Anaesth Crit Care Pain Med; 2019 Dec; 38(6):665-667. PubMed ID: 31495644
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy and safety of milrinone in the treatment of cerebral vasospasm after subarachnoid hemorrhage: a systematic review.
    Santos-Teles AG; Ramalho C; Ramos JGR; Passos RDH; Gobatto A; Farias S; Batista PBP; Caldas JR
    Rev Bras Ter Intensiva; 2020; 32(4):592-602. PubMed ID: 33470361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intra-arterial milrinone for reversible cerebral vasoconstriction syndrome.
    Bouchard M; Verreault S; Gariépy JL; Dupré N
    Headache; 2009 Jan; 49(1):142-5. PubMed ID: 18647181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating Vasospasm with IV Milrinone: Relax (The Vessel) or Don't Do It!
    Robert-Edan V; Lakhal K
    Neurocrit Care; 2023 Oct; 39(2):547-548. PubMed ID: 37434104
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.